Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA’s Plan B Approval Illegal, Unconstitutional, Federal Suit Says

This article was originally published in The Tan Sheet

Executive Summary

FDA's approval for OTC distribution of Plan B emergency contraceptive violated the Food, Drug, and Cosmetic and Administrative Procedure acts, as well as the due process clause of the Constitution, according to an April 12 lawsuit seeking to overturn the approval

You may also be interested in...



Plan B Plaintiffs Expect to Face Court’s “Huge Deference” To FDA

A recently filed federal lawsuit challenging FDA's approval for OTC distribution of Plan B may present good cause for contesting the drug's approval, but will likely face an uphill battle, the plaintiffs acknowledge

Plan B Plaintiffs Expect to Face Court’s “Huge Deference” To FDA

A recently filed federal lawsuit challenging FDA's approval for OTC distribution of Plan B may present good cause for contesting the drug's approval, but will likely face an uphill battle, the plaintiffs acknowledge

Plan B Plaintiffs Expect to Face Court’s “Huge Deference” To FDA

A recently filed federal lawsuit challenging FDA's approval for OTC distribution of Plan B may present good cause for contesting the drug's approval, but will likely face an uphill battle, the plaintiffs acknowledge

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100403

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel